Shortage of saline solution continues for months
Posted July 16, 2014
A shortage of saline solutions for intravenous administration—particularly 0.9 percent sodium chloride solution, or normal saline solution—has continued for months.
On Jan. 17, the Food and Drug Administration reported that the agency was aware of the situation. The FDA stated: “The shortage has been triggered by a range of factors including a reported increased demand by hospitals, potentially related to the flu season.”
The agency has been working with the three U.S. manufacturers of the products—Baxter Healthcare Corp., B. Braun Medical Inc., and Hospira Inc.—to help preserve the supply.
On March 28, the FDA announced that Fresenius Kabi USA LLC would temporarily distribute normal saline solution in the United States from the company’s manufacturing facility in Norway. The agency stated that it also was working with Fresenius Medical Care, which supplies normal saline solution to dialysis centers.
On April 28, the FDA announced that Baxter Healthcare would temporarily distribute normal saline solution in the United States from the company’s manufacturing facility in Spain.
The product most affected by the shortage is 1,000 mL bags of sodium chloride solution, according to the American Society of Health-System Pharmacists’ Drug Shortages Resource Center.
Much more information is available here.